Exemestane and aromatase inhibitors in the management of advanced breast cancer.
about
Controversies in breast cancer: adjuvant and neoadjuvant therapy.Exemestane in early breast cancer: a reviewPhase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupDrug safety evaluation of exemestane.
P2860
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@ast
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@en
type
label
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@ast
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@en
prefLabel
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@ast
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@en
P2860
P356
P1476
Exemestane and aromatase inhibitors in the management of advanced breast cancer.
@en
P2093
J Michael Dixon
P2860
P304
P356
10.1517/14656566.5.2.307
P407
P577
2004-02-01T00:00:00Z